Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma-A Review.

Walia, Arman S; Sweis, Randy F; Agarwal, Piyush K; Kader, Andrew K; Modi, Parth K

Walia, Arman S; Sweis, Randy F; Agarwal, Piyush K; Kader, Andrew K; Modi, Parth K.

Afiliação

Walia AS; Department of Urology, University of California San Diego, La Jolla, CA 92093, USA.
Sweis RF; Department of Medicine, University of Chicago, Chicago, IL 60612, USA.
Agarwal PK; Department of Surgery, University of Chicago, Chicago, IL 60637, USA.
Kader AK; Department of Urology, University of California San Diego, La Jolla, CA 92093, USA.
Modi PK; Department of Surgery, University of Chicago, Chicago, IL 60637, USA.

Cancers (Basel) ; 14(1)2021 Dec 24.

Article em En | MEDLINE | ID: mdl-35008237

Palavras-chave

bladder; cancer; cost; immunotherapy; systemic; urothelial; value

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google